Delivery Order SPE2DE21D7009-SPE2D626F21V6
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a fixed-price delivery order valued at $6,176.10 on December 15, 2025, for pain management medical devices and services. The delivery order, which is a child contract under a larger indefinite delivery vehicle, will be performed in Valencia, California, and is scheduled for completion by December 29, 2025. This award carries no small business set-aside designation and is funded through the...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $41,430.34 for pain management medical devices and services. This fixed-price contract with economic price adjustment was awarded on September 9, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a fixed-price delivery order valued at $43,709.82 on December 15, 2025, for pain management medical devices and equipment. The delivery order, with a ultimate completion date of December 22, 2025, will be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This award carries no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,825.75 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment authority is performance-based in Valencia, California, and carries an ultimate completion date of December 5, 2025. The contract was awarded by the Medical Supply Chain, a defense-related procurement entity under the Department of...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $31,771.22 fixed-price delivery order (Contract No. 4570331497) on December 15, 2025, for pain management medical devices and related services. The award carries an economic price adjustment clause and is scheduled for completion by December 29, 2025. This delivery order was issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,948.40 on September 9, 2025, for pain management medical devices and services under a Defense Logistics Agency (DLA) Troop Support Medical contract. This fixed-price delivery order with economic price adjustment has an ultimate completion date of September 16, 2025, and will be performed at the contractor's facility in Valencia, California. The award is part of the...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,838.13 for pain management medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on November 28, 2025, with an ultimate completion date of December 17, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division, a defense-related procurement entity supporting the Department of Defense. The...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F21V6Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,834.00 on November 28, 2025, for pain management medical devices and services. The delivery order, which is fixed price with economic price adjustment provisions, has an ultimate completion date of December 5, 2025, and will be performed in Valencia, California. This award represents a child delivery order issued under Boston Scientific Neuromodulation's larger indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical branch, the SPE2DE program, which is valued at approximately $83.1 million and extends through August 16, 2026. The contract carries no small business set-aside designation. This delivery order supports the Medical Supply Chain, a defense-related procurement entity, in providing non-opioid pain management solutions to military treatment facilities and Veterans Affairs medical centers. Boston Scientific Neuromodulation specializes in advanced neuromodulation therapies, including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices designed to assist service members and veterans in managing chronic pain. The company's extensive federal contract history demonstrates consistent performance as a sole-source provider of specialized pain management technologies to the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/27/25 |